Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
Casirivimab Emergency use authorization Experimental Antiviral Jan/26/2022 4 11
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
6D3 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 1 0
8-{3-hydroxy-4-[(7-hydroxynaphthalen-2-yl)oxy]phenoxy}-1,4-benzodioxin-5-ol Potential treatment - theoretical effect Experimental Antiviral Apr/25/2021 1 0
Sargassum horneri polysaccharide extract Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021 1 0
Quinine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/09/2021 2 0
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5